Lamivudine
Lamivudine (marketed as Zeffix and Epivir HBV) is an antiviral medication that prevents viral replication within the body. It belongs to a group of medicines known as nucleoside reverse transcriptase inhibitors. Four formulations are available, including Combivir and Triumeq, supporting management of chronic viral conditions.
Epivir HBV
Chronic Hepatitis B
100mg
Lamivudine 100mg film-coated tablets, the hepatitis B strength, used in the management of chronic hepatitis B. It inhibits the viral reverse transcriptase.
Key points
- Used long-term either as part of an HIV combination regimen or on its own to control chronic hepatitis B and protect the liver.
- Acts as a decoy building block that stops the reverse transcriptase enzyme from completing viral DNA, curbing replication.
- Kidney function needs checking beforehand, since impaired renal clearance can require a dose adjustment for this medicine.
What is Lamivudine?
Lamivudine is a nucleoside analogue medication designed to interrupt the replication cycle of specific viruses. By mimicking the structures of viral components, it interferes with enzymes required for viral growth, thereby reducing the viral load. It is primarily used for long-term therapeutic regimens to control chronic viral activity.
What Lamivudine is used for
This medication is indicated for the treatment of HIV Infection in combination with other active ingredients to suppress systemic viral levels. It is also used in the management of Chronic Hepatitis B to prevent liver damage associated with continuous viral replication. Treatment regimens focused on these conditions typically require long-term adherence to maintain viral suppression.
How does Lamivudine work?
Inside the body, the medication acts as a false building block for viral DNA. Viruses like HIV and hepatitis B require an enzyme called reverse transcriptase to copy their genetic material and infect healthy cells. Lamivudine blocks this enzyme, causing the virus to terminate the production of its DNA chain. When viral replication is stalled, the overall burden of the virus in the bloodstream decreases, allowing the immune system to function more effectively.
Lamivudine brands and forms
The availability of Lamivudine includes both original developer brands and generic versions. For patients within HIV Management and broader Antivirals protocols, these options provide flexibility in administration. Available formulations include film-coated tablet and standard tablet forms. These variations ensure that consistent dosing can be maintained according to specific clinical requirements for different age groups and conditions.
Safety overview for Lamivudine
What to check before using this medicine
Verify that the chosen product strength matches the requirements stated in a clinical plan. Check the ingredient list to ensure no hypersensitivity to lamivudine or other components in the formulation exists. Patients with underlying kidney function issues should communicate this to a provider, as adjustments may be required.
Possible reactions and tolerability
Individuals may experience varied responses to antiviral therapies. Reported effects from clinical use can include gastrointestinal discomfort, headache, or fatigue. While many users tolerate the treatment well, any persistent symptoms should be noted and discussed with a qualified professional.
Interactions and health factors
Other medications, including those for different chronic conditions, may interact with antiviral agents. Full disclosure of all ongoing supplements and medicines to a provider is necessary to avoid unintended reactions. Lifestyle factors, including diet and alcohol consumption, can also impact how the liver and kidneys process the medication. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.